Journal Mobile Options
Table of Contents
Vol. 19, No. 6, 1998
Issue release date: November–December

SCC Antigen in Malignant and Nonmalignant Squamous Lesions

Torre G.C.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Squamous cell carcinoma (SCC) antigen (Ag) present and expressed in normal epithelium and epithelial tissues is used primarily as tumor marker of SCC of the uterine cervix. In this review, we considered factors interfering in vitro with the collection of samples and assay procedures, benign and malignant nongynecological diseases which may be the cause of elevated serum levels of SCC Ag. Contamination with skin or saliva strongly influences SCC Ag levels. SCC Ag is elevated in several benign lesions, including pulmonary (tuberculosis, adult respiratory distress syndrome, pulmonary infiltration with eosinophilia, sarcoidosis, bronchogenic cyst) and skin (eczema, pemphigus, erythroderma epidermitis, psoriasis) diseases. Elevations are observed in SCC malignancies of the head and neck, esophagus, skin, lung, urothelium, anal canal and vulva.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621–1628.
  2. Torre GC, Chisale’ E, Barbetti V, Rembado R, Bianchi D, Bugiardini G, Capelli M, Plate L, Marabini A, Orlandi C, Cortesi E, Vecchione A: Determination of serum levels of SCC antigen in patients with malignant and nonmalignant gynecological diseases. A multicenter study; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 78–85.
  3. Kato H, Morioka H, Hashimoto K, Suehiro Y, Hayashi K, Kobayashi M, Torigoe T: SCC antigen and its clinical applications; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 1–14.
  4. Kato H: Squamous cell carcinoma antigen; in Sell S (ed): Serological Cancer Markers. Totowa, Humana Press, 1992, pp 437–451.
  5. Fateh-Moghadam A, Stieber P: Sensible Use of Tumor Markers, ed 2. Marloffstein, Hartmann, 1993, p 22.
  6. Kudo H, Yamamoto M, Miyachi Y, Danno K, Imamura S: Increased serum levels of squamous cell carcinoma-related antigen in pemphigus. Br J Dermatol 1988;118:471–474.
  7. Numahara T, Nakashima K, Yamamoto Y, Nishimoto M: Significance of squamous cell carcinoma-related antigen in psoriasis and generalized eczema. Dermatologica 1989;178:73–74.

    External Resources

  8. Duk JM, van Voorst Vader, ven Hoor KA, Hollema H, Doeglas HM, de Bruijn HWA: Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 1989;64:1652–1656.
  9. Campbell B, De Ambrosis B: Squamous cell carcinoma antigen in patients with cutaneous disorders. J Am Acad Dermatol 1990;22:639–642.
  10. Sedona P, Bassi R, Fabbian PR: Valutazione dello squamous cell carcinoma associated antigen (SCC) nelle dermopatie – Risultati preliminari. Acta Oncol 1993;14:81–86.
  11. Quadri G, Torre GC, Lanfranco E: Erythemato, squamous, chronic dermatoses, psoriasis: A misleading factor of the interpretation of elevated levels of SCC antigen. Tumor Biol 1993;13:1–2, 86.
  12. Tsukahara T, Otoyama K, Horiuchi Y: Significance of elevated serum squamous cell carcinoma (SCC)-related antigen and lactate dehydrogenase (LDH) levels in senile erythroderma following eczema. J Dermatol 1993;20:346–350.
  13. Horiuchi Y, Tsukahara T, Otoyama K: Immunohistochemical study of elevated expression of squamous cell carcinoma (SCC) related antigens in erythrodermic epidermis. J Dermatol 1994;21:67–72.
  14. Gelfant S, Ozawa A, Chalker DK, Smith JG Jr: Circadian rhythm and differences in epidermal and dermal cell proliferation in uninvolved and involved psoriatic skin in vivo. J Invest Dermatol 1982;78:58–62.

    External Resources

  15. Suzuki K, Suzuki T, Akiyama Y, Takashima Y, Yamada T, Kawashima M, Sato M, Sato H, Inui K, Wada H: Serum and pleural SCC-antigen levels in patients with pulmonary tuberculosis. Kekkaku 1993;68:551–557.
  16. Lai RS, Hsu HK, Lu JY, Ger LP, Lai NS: CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non small cell lung cancer. Chest 1996;109:995–1000.
  17. Ashitani J, Mukae H, Ihiboshi H, Taniguchi H, Mashimoto H, Motsukura S: Adult respiratory distress syndrome with increased serum and bronchoalveolar lavage fluid levels of squamous cell carcinoma-related antigen. Intern Med 1996;35:497–501.

    External Resources

  18. Sakito O, Kodota J, Kohno S, Itoh N, Takehara D, Hara K: Pulmonary infiltration with eosinophilia and increased serum levels of squamous cell carcinoma-related antigen and neuron specific enolase. Intern Med 1994;33:550–553.

    External Resources

  19. Bando M, Tani K, Kohrai F, Sano T, Kitamura S: A case of sarcoidosis with elevated SCC antigen in the serum and broncho-alveolar lavage fluid which was difficult to distinguish from lung cancer. Nippon Kyobu Shikkan Gakkai Zasshi 1994;32:95–100.
  20. Tatsuta M, Nishi T, Yamada T, Ikeda M, Inui I, Hoshi O, Kawasaki T, Satomi T, Sakaguchi A: A case of bronchogenic cyst in the posterior mediastinum with high level of serum SCC antigen. Kyobu Geka 1993;46:623–625.
  21. Yagi H, Danno K, Maruguchi Y: Significance of squamous cell carcinoma (SCC)-related antigen in cutaneous SCC: A preliminary report. Arch Dermatol 1987;123:902–906.
  22. Yamamoto T, Mamada A, Kondo S, Yamaguchi J, Ohara K: High level of serum squamous cell carcinoma related antigen in a case of Bowen’s disease. Dermatologica 1990;180:244–246.
  23. Hara M, Hunayama M, Aiba S, Suetake T, Watanabe M, Tanaka M, Tagami H: Acrokeratosis paraneoplastica (Bazex syndrome) associated with primary cutaneous squamous cell carcinoma of the lower leg, vitiligo and alopecia areata. Br J Dermatol 1995;133:121–124.
  24. Johnson JT, Wagner RL, Eibling DE, Su S: Radioimmunoassay for SCC antigen in the diagnosis of squamous cell carcinoma of the head and neck: A preliminary report; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 112–121.
  25. Fischbach W, Rink C: SCC Antigen: A sensitive and specific tumor marker for squamous cell carcinoma. Dtsch Med Wochenschr 1988;113:289–293.

    External Resources

  26. Eibling DE, Johnson JT, Wagner RI, Su S: SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Laryngoscope 1989;99:117–124.

    External Resources

  27. Friedrich RE, Plambeck K, Hellner D, Thoms VW, Bahlo M, Klapdor R: Initial values of tumor associated antigens (TAA) in the sera of patients with primary oral squamous cell carcinomas; in Klapdor R (ed): Current Tumor Diagnosis: Applications, Clinical Relevance, Research, Trends. Cancer of the Lung – State and Trends in Diagnosis and Therapy. Munich, Zuckschwerdt, 1994, pp 3–6.
  28. Lara PC, Cuyas JM: The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer. Cancer 1995;76:758–764.
  29. Molina R, Torres MD, Moragas M, Perez-Villa J, Filella X, Jo J, Farrus B, Gimenez N, Traserra J, Ballesta AM: Prognostic significance of SCC antigen in the serum of patients with head and neck cancer. Tumor Biol 1996;17:81–89.
  30. Wollenberg B, Jan V, Schmit U, Hofmann K, Stiber P, Fateh-Moghadam A: Cyfra 21 1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Anticancer Res 1996;16:3117–3124.

    External Resources

  31. Rayo JL, Talavera RG, Martin M, et al: Serum levels and significance of SCC as tumoral marker in head and neck oncology. Proc XVIth ISOBM Meet, 1988, p 169.
  32. Pectasides D, Brourazanis J, Economides N, Pozadzidou P, Gogou L, Koutsiouba P, Athanassiou A: Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumor-associated trypsin inhibitor (TATI) for monitoring head and neck cancer. Int J Biol Markers 1993;8:81–87.
  33. Grosskopf J: Der Stellenwert des Tumor Markers SCC bei der Diagnose, Verlaufsbeobachtung und Therapie, Effizienzendkontrolle von malignen Tumoren des Ano-Traktes; thesis, Ludwig Maximilians Universität München, 1993.
  34. Snydermann CH, Damico F, Wagner R, Ibling DE: A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Arch Otorhinolaryngol Head Neck Surg 1995;121:1294–1297.
  35. Burtin P, Ben Bouali AK, Boyer J, Daver A, Larra F, Ronceray J: Diagnostic and prognostic value of serum levels of SCC antigen in patients with espohageal epidermal carcinoma. A retrospective study of 64 patients; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 142–148.
  36. Ideka K: Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma. Nippon Geka Gakkai Zasshi 1991;92:387–396.
  37. Gion M, Mione R, Dittadi R, Bruscagnin G, Tremolada C, Zari C, Dalla Palma P: SCC antigen in patients with esophageal carcinoma; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 130–141.
  38. Albertino B, Pecchio F, Rapellino M, Casalegno PA, Gasprre G, Del Poli M: Il TA4- SCC nella diagnosi precoce del’e carcinoma squamoso dell’esofago. Boll Soc Piemontese Chir 1988;LVIII:9–13.
  39. Burtin P, Daver A, Charneau J, Ben BA, Larra F, Boyer J: Squamous cell carcinoma antigen in epidermoid cancer of the esophagus: Diagnostic value (letter). Gastroenterol Clin Biol 1989;13:636–637.
  40. Hirata S, Yamazaki K, Yokoyama Y, Ueda M, Kudo Y, Samejima N: Studies on antigen associated with human squamous cell carcinoma (SCC antigen) in patients with esophageal carcinoma. Nippon Geka Gakkai Zasshi 1989;90:267–272.

    External Resources

  41. Matsuda H, Mori M, Tsujitani S, Ohno S, Kuwano H, Sugimachi K: Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein cells in human malignant esophageal tissues. Cancer 1990;65:2261–2265.
  42. Ebert W, Muley T, Drings P: Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 1996;16:2161–2168.

    External Resources

  43. Matsubara Y, Yasuda Y, Hanawa T, Miyamoto Y, Minomiya K, Hatekanaka R, Funatsu T, Ikeda S: SCC-antigen in patients with lung cancer. Nippon Gan Chiryo Gakkaishi 1986;21:1036–1048.
  44. Ballesta AM, Molina R, Filella X, Nolla M, Marin JL, Elena M, Balague A: SCC antigen in lung diseases: Preliminary results; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 180–185.
  45. Bonfrer JMG, van Zandwijk NN, Hilgers FJM: SCC levels in patients with squamous cell carcinoma of the lung; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC antigen in the management of squamous cell carcinoma. Princeton, Excerpta Medica, 1987, pp 171–174.
  46. Bugiardini G, Capelli M, Plate L, Bianchi D, Falcone F, Faraca M, Lagatta P: Evaluation of SCC antigen in lung cancer; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 175–179.
  47. Castelli M, Salvati F, Cruciani A, Portalone L, Giannarelli D, Ferrini U: Comparative analysis of CEA and SCC serum markers with IAP in human cancer. Int J Biol Markers 1989;4:45–50.

    External Resources

  48. De Cos SJ, Masa F, de la Cruz JL, Disider C, Vergara C: Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer. Chest 1994;105:773–776.
  49. Ebert W, Leichtweis B, Bulzebruck H, Drings P: The role of IMxSCC assays in the detection and prognosis of primary squamous cell carcinoma of the lung. Diagn Oncol 1992;2:203–210.
  50. Margolis ML, Hyzy JB, Schenken LL, Schepart BS: Serum tumor markers in non-small cell lung cancer. A comparative analysis. Cancer 1994;73:605–609.
  51. Mizushima Y, Tsuij H, Izumi S, Hirata H, Kin Y, Kawasaki A, Matsui S, Yano S: Clinical evaluation of five tumor marker assays in patients with lung cancer. Anticancer Res 1991;11:91–95.
  52. Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakajima S: Assessment of serum CYFRA 21-1 in lung cancer. Cancer 1996;77:1274–1277.
  53. Pecchio F, Rapellino M, Ricci E, Casadio C, Moscato D, Adamo R, Miserendino L, Sansalvadore F: TA4-SCC versus CEA sensitivity for lung cancer. Tumori 1988;31:393–395.
  54. Ebert W, Kayser KW, Bulzebruck H: Concentrations of SCC antigen in patients with lung cancer; in Kato H, de Bruijn HWA, Ebert W, Herberman RB, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princeton, Excerpta Medica, 1987, pp 154–161.
  55. Mino-Miyagawa N, Kimura Y, Hamamoto K: Tumor antigen 4. Its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus. Cancer 1988;62:730–734.
  56. Body JJ, Sculioer JP, Raymakers N, Paesmans M, Rabez P, Libert P, Richez M, Dabonis G, Lacroix H, Burean G, Thiriaux J, Lecomte J, Brohee D, Mommen P, Fruhling J, Klastersky J: Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. Cancer 1990;65:1552–1556.
  57. Picardo AL, Torres AJ, Maestro M, Ortega D, Garcia-Asenjo JA, Muguerza JM, Hernando F, Diez M, Balibrea JL: Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125 and CA 50 cytosolic content in non small cell lung cancer. Cancer 1994;73:2305–2311.
  58. Takahashi Y, Shinoda I, Takeuchi T, Kuriyama M, Ban Y, Kawada Y: Clinical assay of serum SCC Ag in urothelial cancers. Int J Biol Markers 1988;3:15–18.

    External Resources

  59. Tada K, Takeuchi T, Tanaka T, Iwata H, Kanematsu M, Kuriyama M, Ban Y, Kawada Y: Retrovesical squamous cell carcinoma associated with toxoplasmosis: Diagnostic images, serum detection of SCC-antigen, and successful treatment by M-VAC-regimen. J Surg Oncol 1989;40:61–64.

    External Resources

  60. Yamazaki K, Kumamoto Y, Tsukamoto T: Expression of squamous cell carcinoma-associated antigen in bladder cancer cells. A comparative study with the expression of proliferating cell nuclear antigen (PCNA). Nippon Hinyokika Gakkai Zasshi 1994;85:589–598.
  61. Tsukamoto T, Kumamoto Y, Ohmura K, Miyao N, Nammbu A, Takagi Y, Itoh N: Squamous cell carcinoma -associated antigen in uroepithelial carcinoma. Urology 1992;40:477–484.
  62. Moreno-Sierra J, Maestro de las Casas M, Ortega Herredia MD, Rodriguez Mokina J, Lopez Asenjo J, Blanco Jimenez E, Hermida Futierrez J, Esteban Fuertes M, Resel Estevez L: Determination of serum SCC antigen in transitional cell carcinoma of the bladder. Actas Urol Esp 1994;18:26–28.
  63. Wishnow KI, Johnson DE, Fritsche HA: Squamous cell carcinoma antigen in genitourinary tumors. Int J Biol Markers 1989;4:226–228.

    External Resources

  64. Petrelli N, Shaw NY, Bhargava A, Herrera B, Sischy J, Daufelet J, Mittelman A: Squamous cell carcinoma antigen (SCC) as a marker in patients with primary squamous cell carcinoma of the anal canal. Assoc Am Cancer Res 1987;48:182.
  65. Fontana X, Lagrange JL, Francois E, Bourry J, Chanvel P, Sordage M, Lapalus F, Namer M: Assessment of squamous cell carcinoma antigen (SCC) as a marker of epidermoid carcinoma of the anal canal. Dis Colon Rectum 1991;34:126–131.
  66. Kato H: Recent progress in biology and clinical use of squamous cell carcinoma antigen. Tumour Marker Update 1996;8:177–179.
  67. Kitao T, Miyaishi S, Yamamoto Y, Ishizu H: Identification of human skin from a tissue fragment by detection of squamous cell carcinoma - related antigen using an enzyme immunoassay. Forensic Sci Int 1996;83:81–86.
  68. Tsukamoto T: Establishment and characterization of a cell line (KU-8) from squamous cell carcinoma of the penis. Keio J Med 1989;38:277–293.

    External Resources

  69. Numa F, Takeda O, Nakata M, Nawata S, Tsunaga N, Hirabayashi K, Suminmi Y, Kato H, Hamanaka S: Tumor necrosis factor - alpha stimulates the production of squamous cell carcinoma antigen in normal squamous cells. Tumor Biol 1996;27:97–101.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50